Retinoid Repression of HIV Through Chromatin Remodeling

类视黄醇通过染色质重塑抑制 HIV

基本信息

  • 批准号:
    6632387
  • 负责人:
  • 金额:
    $ 28.53万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2001
  • 资助国家:
    美国
  • 起止时间:
    2001-07-01 至 2005-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): HIV-1 infection leads to an immune response in the host that is thought to resolve the high levels of viremia found during the acute phase of infection. Chronic infections are possible because HIV-1 has evolved to evade the host immune response. One strategy of immune evasion used by HIV-1 is the establishment of latent infections. Vitamin A metabolites, including all-trans retinoic acid (RA), are natural repressors of HIV1 expression and may play a role in the establishment and maintenance of viral latency. RA consistently represses HIV-1 replication in primary macrophages that are stimulated by cytokines normally found in high concentrations at local sites, where infected macrophages reside in viva The overall goals of this proposal are to understand how RA represses HIV-1 expression and to determine the role of this process in latency, RA repression of HIV-1 expression is associated with an inhibition in the remodeling and histone H4 hyperacetylation of a nucleosome positioned at the start site of HIV-1 transcription. These results, and the finding that repression requires new cellular protein synthesis, support the hypothesis that RA induces a factor that specifically associates with the viral promoter and thereby prevents chromatin remodeling. The goal of this proposal is to test this hypothesis. There are two specific aims. The goal of aim I is to evaluate the role of RA as a repressor of HIV-1 replication in cytokine activated primary macrophages and to determine whether repression requires the induction of specific cellular signaling pathways. The goal of aim 2 is to evaluate the role of RA as an regulator of the HIV-1 chromatin structure in established cell lines and primary cells. RA-induced changes in nucleosome binding and the post-translational modification of histones will be examined using in vivo nucleosome mapping and footprinting as well as chromatin immunoprecipitation assays. These aims are part of the long term goal of delineating the molecular mechanisms of retinoid-mediated repression and determining their therapeutic potential.
描述(由申请人提供):HIV-1感染导致免疫

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GREGORY A. VIGLIANTI其他文献

GREGORY A. VIGLIANTI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GREGORY A. VIGLIANTI', 18)}}的其他基金

REAGENT / VECTOR CORE
试剂/载体核心
  • 批准号:
    8504904
  • 财政年份:
    2013
  • 资助金额:
    $ 28.53万
  • 项目类别:
REAGENT / VECTOR CORE
试剂/载体核心
  • 批准号:
    8290054
  • 财政年份:
    2011
  • 资助金额:
    $ 28.53万
  • 项目类别:
REAGENT / VECTOR CORE
试剂/载体核心
  • 批准号:
    8120847
  • 财政年份:
    2010
  • 资助金额:
    $ 28.53万
  • 项目类别:
Co-factors in HIV Mucosal Infection
HIV粘膜感染的辅助因素
  • 批准号:
    7771771
  • 财政年份:
    2008
  • 资助金额:
    $ 28.53万
  • 项目类别:
Co-factors in HIV Mucosal Infection
HIV粘膜感染的辅助因素
  • 批准号:
    7574447
  • 财政年份:
    2008
  • 资助金额:
    $ 28.53万
  • 项目类别:
Co-factors in HIV Mucosal Infection
HIV粘膜感染的辅助因素
  • 批准号:
    8025980
  • 财政年份:
    2008
  • 资助金额:
    $ 28.53万
  • 项目类别:
Co-factors in HIV Mucosal Infection
HIV粘膜感染的辅助因素
  • 批准号:
    7494345
  • 财政年份:
    2008
  • 资助金额:
    $ 28.53万
  • 项目类别:
Co-factors in HIV Mucosal Infection
HIV粘膜感染的辅助因素
  • 批准号:
    8225118
  • 财政年份:
    2008
  • 资助金额:
    $ 28.53万
  • 项目类别:
Retinoid Repression of HIV Through Chromatin Remodeling
类视黄醇通过染色质重塑抑制 HIV
  • 批准号:
    6746875
  • 财政年份:
    2001
  • 资助金额:
    $ 28.53万
  • 项目类别:
Retinoid Repression of HIV Through Chromatin Remodeling
类视黄醇通过染色质重塑抑制 HIV
  • 批准号:
    6511438
  • 财政年份:
    2001
  • 资助金额:
    $ 28.53万
  • 项目类别:

相似海外基金

A targeted combination intervention approach for acute HIV infections to curb the explosive epidemic among high-risk populations in Indonesia
针对急性艾滋病毒感染的针对性组合干预方法,遏制印度尼西亚高危人群的爆发性流行
  • 批准号:
    MR/V035304/1
  • 财政年份:
    2022
  • 资助金额:
    $ 28.53万
  • 项目类别:
    Research Grant
IMPAACT RELATED PROTOCOLS FOR THE RESEARCH ON TREATMENT, PREVENTION, DIAGNOSIS AND EPIDEMIOLOGY OF HIV INFECTIONS
HIV 感染的治疗、预防、诊断和流行病学研究的影响相关方案
  • 批准号:
    10369859
  • 财政年份:
    2021
  • 资助金额:
    $ 28.53万
  • 项目类别:
Determining the mechanisms of vascular CD8 T cell activation in CMV and HIV infections
确定 CMV 和 HIV 感染中血管 CD8 T 细胞激活的机制
  • 批准号:
    10461964
  • 财政年份:
    2021
  • 资助金额:
    $ 28.53万
  • 项目类别:
Determining the mechanisms of vascular CD8 T cell activation in CMV and HIV infections
确定 CMV 和 HIV 感染中血管 CD8 T 细胞激活的机制
  • 批准号:
    10326617
  • 财政年份:
    2021
  • 资助金额:
    $ 28.53万
  • 项目类别:
Combination HIV Prevention: Using anti-retroviral and anti-inflammatory medications to prevent new HIV infections
HIV 联合预防:使用抗逆转录病毒和抗炎药物预防新的 HIV 感染
  • 批准号:
    404211
  • 财政年份:
    2018
  • 资助金额:
    $ 28.53万
  • 项目类别:
    Operating Grants
BALTIMORE: PROJECTS TO REDUCE HIV INFECTIONS AND IMPROVE ENGAGEMENT IN HIV MEDICAL CARE AMONG MSM
巴尔的摩:减少艾滋病毒感染和提高男男性行为者参与艾滋病毒医疗护理的项目
  • 批准号:
    9078083
  • 财政年份:
    2015
  • 资助金额:
    $ 28.53万
  • 项目类别:
Health Department Demonstration Projects to Reduce HIV Infections and Improve Engagement in HIV Medical Care among Men Who Have Sex with Men (MSM) and Transgender Persons
卫生部示范项目旨在减少男男性行为者 (MSM) 和跨性别者的艾滋病毒感染并提高他们对艾滋病毒医疗护理的参与度
  • 批准号:
    9079323
  • 财政年份:
    2015
  • 资助金额:
    $ 28.53万
  • 项目类别:
REDUCING HIV INFECTIONS AND IMPROVING ENGAGEMENT IN HIV MEDICAL CARE AMONG MSM IN MEMPHIS TN
减少田纳西州孟菲斯市 MSM 的 HIV 感染并提高其对 HIV 医疗护理的参与度
  • 批准号:
    9079336
  • 财政年份:
    2015
  • 资助金额:
    $ 28.53万
  • 项目类别:
Double-Negative T cells in SIV and HIV Infections
SIV 和 HIV 感染中的双阴性 T 细胞
  • 批准号:
    8472130
  • 财政年份:
    2012
  • 资助金额:
    $ 28.53万
  • 项目类别:
REDUCING HIV INFECTIONS AMONG COMMERCIAL SEX WORKERS IN GERT SIBANDE DISTRICT TAV
减少格特西班德区 TAV 商业性工作者的艾滋病毒感染
  • 批准号:
    8532661
  • 财政年份:
    2011
  • 资助金额:
    $ 28.53万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了